PDL BioPharma Inc. (PDLI:NASDAQ) Investor Relations Material

Overview

PDL BioPharma is a company that operates in the biopharmaceutical sector, focusing on managing intellectual property and investing in royalty-bearing assets. The company's main strategy involves acquiring and licensing patents from other biotech firms and collecting royalties on the sales of their licensed products. PDL BioPharma has a diverse portfolio of assets in various therapeutic areas, including oncology, infectious diseases, and central nervous system disorders. With a strong track record of generating consistent cash flows from its intellectual property assets, the company has become an attractive investment opportunity for those seeking exposure to the growing biopharmaceutical industry.

Frequently Asked Questions

What is PDL BioPharma Inc.'s ticker?

PDL BioPharma Inc.'s ticker is PDLI

What exchange is PDL BioPharma Inc. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are PDL BioPharma Inc.'s headquarters?

They are based in Incline Village, Nevada

How many employees does PDL BioPharma Inc. have?

There are 51-200 employees working at PDL BioPharma Inc.

What is PDL BioPharma Inc.'s website?

It is http://www.pdl.com

What type of sector is PDL BioPharma Inc.?

PDL BioPharma Inc. is in the Services sector

What type of industry is PDL BioPharma Inc.?

PDL BioPharma Inc. is in the Business Services industry

Who are PDL BioPharma Inc.'s peers and competitors?

The following five companies are PDL BioPharma Inc.'s industry peers:

- Cinedigm

- Asta Funding

- Bank Polska Kasa Opieki

- Conduent

- Atento